Center for Biologics Evaluation and Research (U.S.) & Center for Drug Evaluation and Research (U.S.). (2004). Guidance for industry and clinical investigators: The use of clinical holds following clinical investigator misconduct. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research.
Chicago Style (17th ed.) CitationCenter for Biologics Evaluation and Research (U.S.) and Center for Drug Evaluation and Research (U.S.). Guidance for Industry and Clinical Investigators: The Use of Clinical Holds Following Clinical Investigator Misconduct. Rockville, MD: U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, 2004.
MLA (9th ed.) CitationCenter for Biologics Evaluation and Research (U.S.) and Center for Drug Evaluation and Research (U.S.). Guidance for Industry and Clinical Investigators: The Use of Clinical Holds Following Clinical Investigator Misconduct. U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research : Center for Drug Evaluation and Research, 2004.